Odile Launay

13.8k total citations
274 papers, 6.0k citations indexed

About

Odile Launay is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Odile Launay has authored 274 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Epidemiology, 103 papers in Infectious Diseases and 74 papers in Health. Recurrent topics in Odile Launay's work include Influenza Virus Research Studies (82 papers), Vaccine Coverage and Hesitancy (74 papers) and HIV Research and Treatment (44 papers). Odile Launay is often cited by papers focused on Influenza Virus Research Studies (82 papers), Vaccine Coverage and Hesitancy (74 papers) and HIV Research and Treatment (44 papers). Odile Launay collaborates with scholars based in France, United States and Belgium. Odile Launay's co-authors include Pierre Verger, Olivier Lortholary, Pierre Loulergue, Françoise Dromer, C. Pulcini, Paul Loubet, Simone Mathoulin‐Pélissier, Patrick Peretti‐Watel, Jean-Louis Bresson and John Wood and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Investigation.

In The Last Decade

Odile Launay

262 papers receiving 5.9k citations

Peers

Countries citing papers authored by Odile Launay

Since Specialization

Citations

This map shows the geographic impact of Odile Launay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Odile Launay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Odile Launay more than expected).

Fields of papers citing papers by Odile Launay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Odile Launay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Odile Launay. The network helps show where Odile Launay may publish in the future.

Co-authorship network of co-authors of Odile Launay

This figure shows the co-authorship network connecting the top 25 collaborators of Odile Launay. A scholar is included among the top collaborators of Odile Launay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Odile Launay. Odile Launay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study 2025 ·Nature Communications ·François Rannou, (unknown), Christelle Nguyen, Camille Daste, (unknown), Marie‐Martine Lefèvre‐Colau, Odile Launay, (unknown), Barbara Ruiz, (unknown), (unknown), (unknown), Hervé Do, (unknown), Francis Bérenbaum, Marie‐Christophe Boissier, Jean‐Pierre Salles, Jean-François Zagury	0
2	Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD) 2025 ·Lara D. Veeken ·Benjamin Thoreau, (unknown), Philippe Chafey, Guilhem Clary, Morgane Le Gall, Cédric Broussard, Odile Launay, David Launay, É. Hachulla, C. Deligny, Alban‐Elouen Baruteau, Anaïs Vallet‐Pichard, Benjamin Chaigne, A. Yaïci, Olivier Sitbon, David Montani, Marc Humbert, Luc Mouthon	0
3	The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021–2022 influenza season 2024 ·Clinical Microbiology and Infection ·Hélène Bricout, (unknown), Nada Assi, Pascal Crépey, (unknown), Karine Mari, J. Gaillat, G. Gavazzi, (unknown), Odile Launay, Anne Mosnier, F. Raguideau, Laurence Watier, Rebecca C. Harris, Ayman Chit	7
4	Répartition des sérotypes de vaccins pneumococciques contenus dans le vaccin dans les pneumonies communautaires nécessitant une hospitalisation chez l'adulte en France 2024 ·SPIRE - Sciences Po Institutional REpository ·(unknown), Xavier Duval, Élisabeth Botelho-Nevers, Fabrice Lainé, Romain Hernu, (unknown), (unknown), Odile Launay, Charles Burdet	1
5	Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population 2024 ·Journal of Medical Economics ·Fabián P. Alvarez, (unknown), F. Bianic, Hélène Bricout, Pascal Crépey, (unknown), G. Gavazzi, (unknown), Odile Launay, (unknown), (unknown), (unknown)	1
6	Impact du pass sanitaire sur la confiance des français vis-à-vis des vaccins en général 2023 ·Amandine Gagneux‐Brunon, Élisabeth Botelho-Nevers, Pierre Verger, (unknown), Odile Launay, Jeremy K. Ward	1
7	Persistance des anticorps neutralisants induits par le vaccin à protéine recombinante souche B1.531 contre les variants Omicron du SARS-COV-2 2023 ·PubMed Central ·Odile Launay, (unknown), Marine Cachanado, Marie Lachâtre, (unknown), Karine Lacombe, Fabrice Lainé, Catherine Schmidt‐Mutter, Xavier de Lamballerie, Tabassome Simon	0
8	Change in self-perceived vaccine confidence in France after the COVID-19 vaccination campaign: A cross-sectional survey in the French general population 2023 ·Health Policy and Technology ·Amandine Gagneux‐Brunon, Élisabeth Botelho-Nevers, Pierre Verger, (unknown), Odile Launay, Jeremy K. Ward	2
9	Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018 2022 ·Influenza and Other Respiratory Viruses ·Magali Lemaître, (unknown), Fabrice Carrat, Pascal Crépey, J. Gaillat, G. Gavazzi, Odile Launay, Anne Mosnier, (unknown), M. Uhart	25
10	Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey 2022 ·Human Vaccines & Immunotherapeutics ·Fadia Dib, Philippe Mayaud, (unknown), Odile Launay, Pierre Chauvin	11
11	A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox 2022 ·Nature Medicine ·Liêm Binh Luong Nguyen, Jade Ghosn, Christine Durier, (unknown), Éric Tartour, (unknown), Tabassome Simon, Brigitte Autran, Inmaculada Ortega‐Pérez, (unknown), Jeremy K. Ward, (unknown), Laurence Meyer, Alexandra Rousseau, Laurence Bérard, Xavier de Lamballerie, Odile Launay	16
12	Efficacy of COVID-19 vaccines: From clinical trials to real life 2021 ·Therapies ·Dominique Deplanque, Odile Launay	22
13	Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study 2021 ·International Journal of Infectious Diseases ·Philippine Eloy, Coralie Tardivon, Guillaume Martin‐Blondel, Margaux Isnard, Paul Le Turnier, Marion Le Maréchal, André Cabié, Odile Launay, Pierre Tattevin, (unknown), Séverine Ansart, François Goehringer, Catherine Chirouze, (unknown), Cédric Laouenan, Manuel Etienne, Duc Nguyen, Jade Ghosn, Xavier Duval	11
14	Online mis/disinformation and vaccine hesitancy in the era of COVID-19: Why we need an eHealth literacy revolution 2021 ·Human Vaccines & Immunotherapeutics ·Fadia Dib, Philippe Mayaud, Pierre Chauvin, Odile Launay	78
15	“Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study 2019 ·PLoS ONE ·Pierre Gantner, (unknown), Laurence Morand‐Joubert, Pierre Frange, Karine Lacombe, Marie-Aude Khuong, Claudine Duvivier, Odile Launay, Marina Karmochkine, C. Arvieux, Amélie Menard, Lionel Piroth, Ana Canestri, (unknown), Gilles Peytavin, Roland Landman, Jade Ghosn, (unknown)	2
16	Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet 2016 ·Vaccine ·Paul Loubet, Caroline Guerrisi, (unknown), Béatrice Blondel, Odile Launay, Marc Bardou, François Goffinet, Vittoria Colizza, Thomas Hanslik, Solen Kernéis	25
17	Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France 2015 ·EBioMedicine ·Pierre Verger, Lisa Fressard, Fanny Collange, Arnaud Gautier, C. Jestin, Odile Launay, Jocelyn Raude, C. Pulcini, Patrick Peretti‐Watel	250
18	Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment 2009 ·Journal of Antimicrobial Chemotherapy ·(unknown), Vincent Jullien, Élie Azria, E. Pannier, Ghislaine Firtion, Anne Krivine, Alexandra Compagnucci, Olivier Tauléra, Laurent Finkielsztejn, Stéphanie Chhun, Guillem Pons, Odile Launay, Jean‐Marc Tréluyer	18
19	Maternal Biochemical Serum Screening for Down Syndrome in Pregnancy With Human Immunodeficiency Virus Infection 2008 ·Obstetrics and Gynecology ·(unknown), Vassilis Tsatsaris, Thomas Schmitz, Yvonne Fulla, Odile Launay, François Goffinet, Élie Azria	9
20	Vaccinations : Bases immunologiques, indications, efficacité, complications 2006 ·La Revue du praticien ·Diane van der Vliet, Odile Launay	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact